Rekombinanter BRD9 Antikörper (AA 547-597)
Kurzübersicht für Rekombinanter BRD9 Antikörper (AA 547-597) (ABIN7455162)
Target
Alle BRD9 Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 547-597
-
Verwendungszweck
- Rabbit anti-BRD9 Recombinant Monoclonal Antibody [BLR153J]
-
Aufreinigung
- Purified
-
Immunogen
- between AA 547 and 597 (C-term)
-
Isotyp
- IgG
-
-
anti-Bromodomain Containing 9 (BRD9) (AA 3-29), (N-Term) antibody
BRD9 Reaktivität: Human, Maus WB, IHC (p) Wirt: Kaninchen Polyclonal RB38154 unconjugated
anti-Bromodomain Containing 9 (BRD9) (AA 338-597) antibodyBRD9 Reaktivität: Human WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Bromodomain Containing 9 (BRD9) (AA 338-597) antibodyBRD9 Reaktivität: Human ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Bromodomain Containing 9 (BRD9) antibodyBRD9 Reaktivität: Human, Maus WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Bromodomain Containing 9 (BRD9) (N-Term) antibodyBRD9 Reaktivität: Human, Maus, Ratte, Hund, Rind (Kuh), Meerschweinchen, Pferd, Kaninchen, Zebrafisch (Danio rerio) WB Wirt: Kaninchen Polyclonal unconjugated
anti-Bromodomain Containing 9 (BRD9) (N-Term) antibodyBRD9 Reaktivität: Human, Maus, Ratte, Hund, Rind (Kuh), Meerschweinchen, Pferd, Kaninchen, Zebrafisch (Danio rerio), Saccharomyces cerevisiae WB Wirt: Kaninchen Polyclonal unconjugated
anti-Bromodomain Containing 9 (BRD9) (AA 51-100) antibodyBRD9 Reaktivität: Human, Maus, Ratte, Hund, Rind (Kuh), Meerschweinchen, Pferd, Kaninchen, Affe, Fledermaus, Schwein WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Bromodomain Containing 9 (BRD9) antibodyBRD9 Reaktivität: Maus, Ratte WB Wirt: Kaninchen Polyclonal unconjugated
anti-Bromodomain Containing 9 (BRD9) (AA 145-194) antibodyBRD9 Reaktivität: Human, Maus, Ratte, Hund, Rind (Kuh), Meerschweinchen, Kaninchen, Zebrafisch (Danio rerio), Affe, Huhn WB Wirt: Kaninchen Polyclonal unconjugated
anti-Bromodomain Containing 9 (BRD9) (AA 168-217) antibodyBRD9 Reaktivität: Human, Maus, Ratte, Hund, Pferd, Zebrafisch (Danio rerio), Affe WB Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
-
IHC: 1:100 to 1:500. Epitope retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections.
IP: 6 μL/1 mg lysate
ICC: 1:100 to 1:500. Epitope retrieval with citrate buffer pH 6.0 is recommended for FFPE cell sections.
WB: 17:40:00
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1000 μg/mL
-
Buffer
- Borate Buffered Saline (BBS) pH 8.2 with 0.09 % Sodium Azide, BSA-Free
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- 2 - 8 °C
-
Haltbarkeit
- 12 months
-
-
- BRD9 (Bromodomain Containing 9 (BRD9))
-
Andere Bezeichnung
- BRD9
-
Hintergrund
- BRD9 plays a role in chromatin remodeling and regulation of transcription. It acts as a chromatin reader that recognizes and binds acylated histones: binds histones that are acetylated and/or butyrylated. BRD9 is a component of SWI/SNF chromatin remodeling subcomplex GBAF that carries out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. BRD9 also orchestrates RAD51-RAD54 complex formation and thereby plays a role in homologous recombination [taken from the Universal Protein Resource (UniProt) www.uniprot.org/uniprot/Q9H8M2].
-
Gen-ID
- 65980
-
UniProt
- Q9H8M2
Target
-
